Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia

Clinical Biochemistry

Volumn 32, Issue 8, 1999, Pages 639-645

  Kamper, Elli F ^a   Papahiliss, Anastasios D ^a   Angelopoulou, Maria K ^a   Kopeikina, Ludmila T ^a   Siakantaris, Marina P ^a   Pangalis, Gerassimos A ^a   Stavrudis, John C ^a  

^a Orthopaedic Department   (Greece)

Author keywords

B CLL; cICAM1; IL 10; Tetranectin

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; LACTATE DEHYDROGENASE; TETRANECTIN;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; BONE MARROW METASTASIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL CHEMISTRY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

AGED; AGED, 80 AND OVER; BLOOD PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-10; LECTINS, C-TYPE; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; NEOPLASM STAGING; REAGENT KITS, DIAGNOSTIC; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0033403423     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(99)00066-1     Document Type: Article

References (47)

1. Dighiero G., Travade P., Chevret S., et al. B-cell chronic lymphocytic leukemia present status and future directions. The French Cooperative Group on CLL. Blood. 78:1991;1901-1914.
2. Rai K.R., Sawitsky A., Cronkite E.P., Chanana A.D., Levy R.N., Pasternack B.S. Clinical staging of chronic lymphocytic leukemia. Blood. 46:1975;219-234.
3. Binet J.L., Auqier A., Dighiero G., et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate analysis. Cancer. 48:1981;198-206.
4. Montserrat E., Rozman C. Chronic lymphocyte leukemia present status . Ann Oncol. 6:1995;219-235.
5. Pangalis GA, Angelopoulou MK, Vassilakopoulos TP, Siakantaris MP, Kittas C. B-Chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: A clinical, morphologic and biologic spectrum of similar disorders. Semin Hematol 1999; 36(2): 104-14.
6. Behr S.I., Korinth D., Schriever F. Differential adhesion pattern of B cell chronic lymphocytic leukemia cells. Leukemia. 12:1998;71-77.
7. Holtet T.L., Graversen J.H., Clemmensen I., Thogersen H.G., Etzerodt M. Tetranectin, a trimeric plasminogen-binding C-type lectin. Protein Sci. 6:1997;1511-1515.
8. Clemmensen I., Petersen L.C., Kluft C. Purification and characterization of a novel, oligomeric plasminogen Krigle-4 binding protein from human plasma tetranectin . Eur J Biochem. 156:1986;327-333.
9. Nielsen B.B., Kastrup J.S., Rasmussen H., et al. Crystal structure of tetranectin a trimeric plasminogen-binding protein with an a-helical coiled coil. FEBS Lett. 412:1997;388-396.
10. Kamper E.F., Kopeikina L., Mantas A., Stefanadis C., Toutouzas P., Stavridis J. Tetranectin levels in patients with acute myocardial infarction and their alterations during thrombolytic treatment. Ann Clin Biochem. 35:1998;400-407.
11. Christensen L., Clemmensen I. Tetranectin immunoreactivity in normal human tissue. Histochemistry. 92:1989;29-35.
12. Nielsen H., Clemmensen I., Kharazmi A. Tetranectin a novel secretory protein from human monocytes . Scand J Immunol. 37:1993;39-42.
13. De Vries T.J., De Wit P.E., Clemmensen I., et al. Tetranectin and plasmin-plasminogen are similarly distributed at the invasive front of cutaneous melanoma lesions. J Pathol. 179:1996;260-265.
14. Christensen L., Clemmensen I. Tetranectin immunoreactivity between benign and malignant breast tissue. Histochemistry. 95:1991;427-433.
15. Nielsen H., Clemmensen I., Nielsen H.J., Drivsholm A. Decreased tetranectin in multiple myeloma. Am J Hematol. 33:1990;142-144.
16. Hogdall C.K., Christensen L., Clemmensen I. The prognostic value of tetranectin immunoreactivity and plasma tetranectin in patients with ovarian cancer. Cancer. 72:1993;2415-2422.
17. Rothlein R., Dustin M.L., Marlin S.D., Springer T.A. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol. 137:1986;1270-1274.
18. Boyd A.W., Wawryk S.O., Burns G.F., Fecondo J.V. Intercellular adhesion molecule-1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms. Proc Natl Acad Sci USA. 85:1988;3095-3099.
19. Dougherty G.J., Murdock S., Hogg N. The function of human intercellular adhesion molecule (ICAM-1) in the generation of an immune response. Eur J Immunol. 18:1988;35-39.
20. Dustin M.L., Springer T.A. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to culture endothelial cells. J Cell Biol. 107:1988;321-331.
21. Warnock R.A., Askari S., Butcher E.C., von Andrian U.H. Molecular mechanisms of lymphocyte homing to peripheral lymph node. J Exp Med. 187:1998;205-216.
22. Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules (review article). Blood. 84:1994;2068-2101.
23. Boyd A.W., Dunn S.M., Fecondo J.V., et al. Regulation of expression of a human intercellular adhesion molecule (ICAM-1) during lymphohematopoietic differentiation. Blood. 73:1989;1896-1903.
24. Vincent A.M., Cawley J.C., Burthem J. Integrin function in chronic lymphocytic leukemia. Blood. 87:1996;4780-4788.
25. Rothlein R., Mainolfi E.A., Czajkowski M., Marlin S.D. A form of circulating ICAM-1 in human serum. J Immunol. 147:1991;3788-3793.
26. Wegner C.D., Gundel R.H., Reilly P., Haynes N., Letts L.G., Rothlein R. Intercellular adhesion molecule 1 (ICAM-1) in the pathogenesis of asthma. Science. 247:1990;456-459.
27. Harning R., Mainolfi E., Bystryn J.C., Henn M., Merluzzi V.J., Rothlein R. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res. 51:1991;5003-5005.
28. Christiansen I., Gidlof C., Wallgren A.C., Simonsson B., Totterman T.H. Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers. Blood. 84:1994;3010-3016.
29. Cortes J., Kurzrock R. Interleukin-10 in non-Hodgkin's lymphoma. Leuk Lymph. 26:1997;251-259.
30. Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by interleukin 10. J Exp Med. 174:1991;1549-1555.
31. De Waal-Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J.E. IL-10 inhibits cytokine synthesis by human monocytes an autoregulatory role of IL-10 produced by monocytes . J Exp Med. 174:1991;1209-1220.
32. Rousset F., Garcia E., Defrance T., et al. IL-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA. 89:1992;1890-1893.
33. Chronic lymphocytic leukemia recommendations for diagnosis, staging and response criteria . Ann Intern Med. 110:1989;236-238.
34. Pangalis G.A., Boussiotis V.A., Kittas C. Malignant disorders of small lymphocytes. Small lymphocytic lymphoma, lymphoplasmacytic lymphoma, and chronic lymphocytic leukemia Their clinical and laboratory relationship . Am J Clin Pathol. 99:1993;402-408.
35. Kamper E.F., Kopeikina L.T., Koutsoukos V., Stavridis J. Plasma tetranectin levels in patients with rheumatoid arthritis. J Rheum. 24:1997;262-268.
36. Jensen B.A., Clemmensen I. Plasma tetranectin is reduced in cancer and related to metastasis. Cancer. 62:1988;8869-8872.
37. Wewer U.M., Albrechtsen R. Tetranectin, a plasminogen Krigle 4-binding protein. Cloning and gene expression pattern in human colon cancer. Lab Invest. 67:1992;253-262.
38. Hogdall C.K., Hogdall E.V., Hording U., et al. Plasma tetranectin and ovarian neoplasms. Gynecol Oncol. 43:1991;103-107.
39. Hogdall C.K., Hogdall E.V., Hording U., Toftager-Larsen K., et al. Use of tetranectin, CA-125 and CASA to predict residual tumor and survival at second-and third-look operations for ovarian cancer. Act Oncol. 35:1996;63-69.
40. Hogdall C.K., Christiansen M., Norgaar-Pedersen B., Bentzen S.M., Kronborg O., Clemmensen I. Plasma tetranectin and colorectal cancer. Eur J Cancer. 31A:1995;888-894.
41. Angelopoulou M.K., Siakantaris M.P., Kourtis J., et al. An adhesion molecule (AM) study of blood and tonsilar lymphocytes in Rai 0 B-chronic lymphocytic leukemia (CLL) patients with tonsilar involvement. Br J Haematol. 93:(Suppl. 2):1996;287.
42. Angelopoulou MK, Kapiris E, Kourtis I, Siakantaris MP, Kittas Ch, Pangalis GA. The adhesion molecules (AM) profile of B-chronic lymphocyte leukemia (B-CLL). Correlation with disease activity. Blood 1997; 90(Suppl. 1): 294b [Abstract].
43. Angelopoulou M.K., Kapiris E., Kourtis L., Siakantaris M.P., Kittas C., Pangalis G.A. The adhesion molecule profile of mantle cell lymphoma (MCL) vs B-chronic lymphocytic leukemia (B-CLL). Blood. 90:(Suppl. 1):1997;522a.
44. Angelopoulou MK, Kontopidou FN, Pangalis GA. Adhesion molecules in B-chronic lymphoproliferative disorders. Semin Hematol 1999; 36(2): 178-97.
45. Molica S., Dattilo A., Mannella A., Domenico L., Levato L. Expression on leukemic cells and serum circulating levels of intercellular adhesion molecule-1 (ICAM-1) in B-cell chronic lymphocytic leukemia implications for prognosis . Leukemia Res. 19:1995;573-580.
46. Egle A., Marschitz I., Posch B., Herold M., Greil R. IL-10 serum levels in B-cells chronic lymphocytic leukemia. Br J Haematol. 94:1996;210-212.
47. Sjoberg J., Aguilar-Santelises M., Sjogren A.M., et al. Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukemia inversely correlates with progression of disease. Br J Heamatol. 92:1996;393-400.